HEMATOPOIETIC/LYMPHOID CANCER
Clinical trials for HEMATOPOIETIC/LYMPHOID CANCER explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC/LYMPHOID CANCER trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC/LYMPHOID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to unleash Body's hidden cancer killers
Disease control OngoingThis study tests an experimental drug called ICT01, which tries to activate a special type of immune cell (gamma delta T cells) to fight cancer. It is for people with advanced solid tumors or blood cancers that have not responded to other treatments. The study first finds a safe …
Matched conditions: HEMATOPOIETIC/LYMPHOID CANCER
Phase: PHASE1, PHASE2 • Sponsor: ImCheck Therapeutics • Aim: Disease control
Last updated May 26, 2026 11:36 UTC
-
Smarter CMV strategy may protect stem cell transplant patients
Disease control OngoingThis study tested a modified approach to prevent and treat cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV therapy could still keep patients safe while reducing unnecessar…
Matched conditions: HEMATOPOIETIC/LYMPHOID CANCER
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 11:30 UTC